Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial
- Won Seog Kim
- , Christian Buske
- , Michinori Ogura
- , Wojciech Jurczak
- , Juan Manuel Sancho
- , Edvard Zhavrid
- , Jin Seok Kim
- , José Ángel Hernández-Rivas
- , Aliaksandr Prokharau
- , Mariana Vasilica
- , Rajinish Nagarkar
- , Dzhelil Osmanov
- , Larry W. Kwak
- , Sang Joon Lee
- , Sung Young Lee
- , Yun Ju Bae
- , Bertrand Coiffier
- Sungkyunkwan University
- Ulm University
- Tokai Central Hospital
- Jagiellonian University in Kraków
- Generalitat de Catalunya
- N N Alexandrov Republican Scientific and Practical Centre of Oncology and Medical Radiology
- Yonsei University
- Hospital Universitario Infanta Leonor
- Minsk City Clinical Oncology Dispensary
- Fundeni Clinical Institute
- Curie Manavata Cancer Centre
- N N Blokhin Russian Cancer Research Centre
- City of Hope National Med Center
- Celltrion
- Hospices civils de Lyon
Research output: Contribution to journal › Article › peer-review
72
Link opens in a new tab
Scopus
citations